Enlon-Plus is a brand name of atropine/edrophonium, approved by the FDA in the following formulation(s):
ENLON-PLUS (atropine sulfate; edrophonium chloride - injectable; injection)
Manufacturer: MYLAN INSTITUTIONAL
Approval date: November 6, 1991
Strength(s): 0.14MG/ML;10MG/ML [RLD]
Has a generic version of Enlon-Plus been approved?
No. There is currently no therapeutically equivalent version of Enlon-Plus available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Enlon-Plus. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Enlon-Plus.
No comments:
Post a Comment